Evidence map›Paper›PMID 36057651›Full record

ArticleProstate cancer and prostatic diseases2024

Clinical management and outcomes of HIV-positive patients newly diagnosed with prostate cancer: a single institution experience.

Mark C Markowski, Filip Pirsl, Jeanne C Keruly, Geetanjali Chander, Richard D Moore, Bryan Lau, Corinne E Joshu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark C MarkowskiDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. mmarko12@jhmi.edu.ORCID 0000-0003-2780-5100
Filip PirslDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jeanne C KerulyDepartment of Medicine, Division of Infectious Disease, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Geetanjali ChanderDepartment of Medicine, Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Richard D MooreDepartment of Medicine, Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Bryan LauDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Corinne E JoshuDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
North American AIDS Cohorts on Collaboration and Design (NAACCORD)U01AI069918 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Keri Nicole Althoff, RICHARD Douglas MOORE · 2006 to 2026
$65.2M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
INSTITUTIONAL RESEARCH CANCER EPIDEMIOLOGY FELLOWSHIPT32CA009314 · NCI · JOHNS HOPKINS UNIVERSITY · PI Corinne E. Joshu, Meghan Bridgid Moran · 1985 to 2026
$11.2M
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIVR01CA250851 · NCI · JOHNS HOPKINS UNIVERSITY · PI Corinne E. Joshu, Bryan Lau · 2020 to 2026
$4.8M
A study to screen HIV+ men for ASIL and anal HPVF32CA093140 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WILKIN, TIMOTHY J · 2001 to 2002
$56k
NCI NIH HHS F32 CA093140NCI NIH HHS P30 CA006973NCI NIH HHS R01 CA250851NCI NIH HHS T32 CA009314NIAID NIH HHS P30 AI094189NIAID NIH HHS U01 AI069918NIDA NIH HHS U01 DA036935
6 · The paper itself

Abstract

introduction10-year outcomes in patients living with HIV who are diagnosed with prostate cancer are unknown.

methods52 patients living with HIV were diagnosed with prostate cancer. Disease-free survival stratified by clinical, pathologic, and HIV characteristics were examined.

resultsNo difference in disease-free survival was observed based on prostate cancer treatment modality, CD4 count, or HIV viral load.

conclusionsProstate cancer outcomes in patients living with HIV are favorable irrespective of treatment modality.

Indexed as

HIV InfectionsProstatic NeoplasmsDisease-Free SurvivalHumansMaleProstate

Identifiers

PMID36057651
PMCPMC9981812

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.